(16 days)
Not Found
No
The document describes a programmable infusion pump with various delivery modes and customization options, but there is no mention of AI or ML technologies being used for decision-making, control, or analysis. The description focuses on pre-programmed functionalities and user configuration.
Yes
The device is used for the controlled delivery of parenteral fluids and patient-controlled analgesia, which are therapeutic interventions.
No
The device is described as an infusion pump for controlled delivery of parenteral fluids, not for diagnosing medical conditions.
No
The device description explicitly states it is a "small, battery-operated peristaltic infusion pump," indicating it is a hardware device with software control, not a software-only medical device.
Based on the provided information, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- Intended Use: The intended use is the "controlled delivery of parenteral fluids," which are administered directly into the body (e.g., intravenously). IVDs, on the other hand, are used to examine specimens taken from the body (like blood, urine, or tissue) to diagnose or monitor conditions.
- Device Description: The description details a "peristaltic infusion pump" that delivers fluids. This aligns with the intended use of administering substances, not analyzing biological samples.
- Lack of IVD Characteristics: There is no mention of analyzing biological samples, reagents, or any other components typically associated with in vitro diagnostics.
Therefore, the Disetronic Multifuse Infusion Pump is a medical device for delivering fluids, not an IVD.
N/A
Intended Use / Indications for Use
The Disetronic Multifuse Infusion Pump, with its accessories, is indicated for the controlled delivery of parenteral fluids, including patient controlled analgesia (PCA), in both the hospital and home care environments.
Product codes
FRN
Device Description
The Disetronic Multifuse pump is a small, battery-operated peristaltic infusion pump that is suited for ambulatory hospital and home use. The pump is extremely versatile. It has been designed to allow the health provider program the pump to provide one of several types of infusion therapies. The pump can be configured as a continuous rate infusion pump with demand bolus capability, a variable rate infusion pump with demand bolus capability, a Patient Controlled Analgesia (PCA) pump, a Total Parenteral Nutrition (TPN) pump or an intermittent infusion pump. The health provider can further customize the pump for a specific patient by allowing or excluding optional programming steps, limiting allowable ranges, adjusting the rate at which boluses are infused and adjusting alarm and display features.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Not Found
Indicated Patient Age Range
Not Found
Intended User / Care Setting
hospital and home care environments.
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies
Not Found
Key Metrics
Not Found
Predicate Device(s)
Reference Device(s)
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 880.5725 Infusion pump.
(a)
Identification. An infusion pump is a device used in a health care facility to pump fluids into a patient in a controlled manner. The device may use a piston pump, a roller pump, or a peristaltic pump and may be powered electrically or mechanically. The device may also operate using a constant force to propel the fluid through a narrow tube which determines the flow rate. The device may include means to detect a fault condition, such as air in, or blockage of, the infusion line and to activate an alarm.(b)
Classification. Class II (performance standards).
0
2/12/99
2.0 SUMMARY OF SAFETY AND EFF
9 O SUMMARY OF SAFETY AND EFFECTIVENESS
"510(k) SUMMARY"
| 9.1 Trade/Proprietary Name: | Disetronic Multifuse Infusion Pump System |
|---|---|
| 9.2 Common/Usual Name: | Peristaltic Infusion Pump and Accessories |
| 9.3 Classification Name: | Infusion Pump/Intravascular Administration Se |
9.4 Comparison to Currently Marketed Devices
The Disetronic Multifuse Infusion Pump is substantially equivalent to the currently marketed Disetronic Multifuse Infusion Pump (K915566).
9.5 Device Description
The Disetronic Multifuse pump is a small, battery-operated peristaltic infusion pump that is suited for ambulatory hospital and home use. The pump is extremely versatile. It has been designed to allow the health provider program the pump to provide one of several types of infusion therapies. The pump can be configured as a continuous rate infusion pump with demand bolus capability, a variable rate infusion pump with demand bolus capability, a Patient Controlled Analgesia (PCA) pump, a Total Parenteral Nutrition (TPN) pump or an intermittent infusion pump. The health provider can further customize the pump for a specific patient by allowing or excluding optional programming steps, limiting allowable ranges, adjusting the rate at which boluses are infused and adjusting alarm and display features.
9.6 Indications for Use
The modified Disetronic Multifuse Pump with its accessories has the same indications and intended use as the currently marketed device.
9.7 Testing
The Disetronic Multifuse Infusion Pump has been designed and tested in accordance with IEC 601-2-24 and associated standards.
9.8 Software
Disetronic has adhered to all software development procedures and Good Quality Assurance procedures. All test results demonstrate that the system specifications and functional requirements were met. Disetronic Medical Systems Certifies that it has verified that the Multifuse Pump system will be unaffected by the potential date recording and computational problems associated with the year-2000 date change.
9.9 Conclusion
Based on the functional comparison, design equivalency and the functional and safety testing, Disetronic has determined that the Multifuse Infusion Pump and accessories are substantially equivalent to currently market device in the United States.
1
Image /page/1/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a stylized eagle with three lines forming its body and head. The eagle is encircled by the text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" in a circular arrangement.
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
FEB 1 2 1999
Disetronic Medical Systems C/O Mr. Lee Leichter Official Correspondent P/L Biomedical 7690 Cameron Circle Fort Myers, Florida 33912
Re : K990259 Disetronic Multifuse Infusion Pump System Trade Name: Regulatory Class: II Product Code: FRN Dated: January 27, 1999 Received: January 27, 1999
Dear Mr. Leichter
We have reviewed your Section 510(k) notification of intent to market the device referenced above and we have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Druq, and Cosmetic Act (Act). You may, therefore, market the device, subject to the general controls provisions The general controls provisions of the Act of the Act. include requirements for annual reqistration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (Premarket Approval), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Requlations, Title 21, Parts 800 to 895. ਬੇ substantially equivalent determination assumes compliance with the Good Manufacturing Practice for Medical Devices: General (GMP) regulation (21 CFR Part 820) and that, through periodic GMP inspections, the Food and Drug Administration (FDA) will verify such assumptions. Failure to comply with the GMP regulation may result in regulatory action. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please note: this response to your premarket notification submission does not affect any obligation you might have under sections 531 through 542 of the Act for devices under the Electronic Product Radiation Control provisions, or other Federal laws or requlations.
2
Page 2 - Mr. Leichter
This letter will allow you to begin marketing your device as described in your 510(k) premarket notification. The FDA findinq of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling requlation (21 CFR Part 801 and additionally 809.10 for in vitro diagnostic devices), please contact the Office of Compliance at (301) 594-4692. Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at (301) 594-4639. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR 807.97). Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its internet address "http://www.fda.gov/cdrh/dsmamain.html".
Sincerely yours,
Timothy A. Ulatowski
Director
Director Division of Dental, Infection Control, and General Hospital Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
3
INDICATIONS FOR USE STATEMENT
510(k) File Number:
Multifuse Infusion Pump Device Name:
Indications For Use:
The Disetronic Multifuse Infusion Pump, with its accessories, is indicated for the controlled delivery of parenteral fluids, including patient controlled analgesia (PCA), in both the hospital and home care environments.
PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NEEDED
Concurrence of CDRH, Office of Device Evaluation (ODE)
Prescription Use (Per 21 CFR 801.19)
OR
Over-The-Counter Use _________________________________________________________________________________________________________________________________________________________
Patricio Caceresle
(Division Sign-Off)
(Division Sign-Off) Division of Dental, Infection Control, and General Hospital Devices 510(k) Number _